Yu-Jung Chen
Affiliations: | Sloan Kettering Institute, New York, NY, United States |
Area:
neural stem cell; cancer biologyGoogle:
"Yu-Jung Chen"Parents
Sign in to add mentor| Luis Parada | grad student | 2016-2021 | Sloan Kettering Institute (Neurotree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Li WF, Chiang MF, Weng HC, et al. (2024) OBI-992, a Novel TROP2-Targeted Antibody-Drug Conjugate, Demonstrates Antitumor Activity in Multiple Cancer Models. Molecular Cancer Therapeutics. OF1-OF13 |
| Chen YJ, Iyer SV, Hsieh DC, et al. (2024) Gliocidin is a nicotinamide-mimetic prodrug that targets glioblastoma. Nature |
| Sun D, Xie XP, Zhang X, et al. (2021) Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression. Cell Stem Cell |
| Wang Z, Sun D, Chen YJ, et al. (2020) Cell Lineage-Based Stratification for Glioblastoma. Cancer Cell |
| Shi Y, Lim SK, Liang Q, et al. (2019) Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma. Nature |